Cancer Therapeutics (CT) Research Program
MECC’s CT program is comprised of multidisciplinary cancer scientists and clinicians focused on identifying new treatment targets and novel cancer therapeutics. Members collaborate closely with MECC and other scientists, as well as with Bronx patient advocates, other onsite programs and, building on the innovative cancer research taking place here, conduct many clinical therapeutic trials at the Cancer Center.
CT Program Leaders
Get to know the scientists who lead our CT Program. These experts guide our efforts to turn the latest scientific discoveries into powerful cancer treatments with the potential to transform lives.
CT Program Members
Our highly collaborative group includes specialists with expertise in multiple areas of cancer research and treatment.
Edward Chu, MD, MMS
Director, Montefiore Einstein Cancer Center and Vice-President of Cancer Medicine
Sheldon M. Feldman, MD
Chief, Division of Breast Surgery & Breast Surgical Oncology Director, Breast Cancer Services Professor, Department of Surgery
Chandan Guha, MD, PhD
Associate Director, Innovation/Tech Transfer, Montefiore Einstein Cancer Center
Balazs Halmos, MD, MS
Associate Director, Clinical Science, Montefiore Einstein Cancer Center
Shalom Kalnicki, MD
Associate Director, Clinical Affairs, Montefiore Einstein Cancer Center
Dennis Y. Kuo, MD
Professor, Department of Obstetrics & Gynecology and Women's Health (Gynecological Oncology)